OppenheimerFunds’s Globus Medical GMED Stock Holding History

OppenheimerFunds’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$264K	Buy	+5,353	New	+$242K	﹤0.01%	1599
2018 Q4	–	Sell	-5,261	Closed	-$299K	–	1822
2018 Q3	$299K	Buy	5,261 +88	+2%	+$4.63K	﹤0.01%	1659
2018 Q2	$261K	Buy	5,173 +1,143	+28%	+$59.6K	﹤0.01%	1682
2018 Q1	$201K	Sell	4,030 -3,231	-44%	-$152K	﹤0.01%	1736
2017 Q4	$299K	Buy	7,261 +320	+5%	+$11.2K	﹤0.01%	1696
2017 Q3	$206K	Buy	6,941 +537	+8%	+$16.4K	﹤0.01%	1811
2017 Q2	$213K	Sell	6,404 -349	-5%	-$11K	﹤0.01%	1804
2017 Q1	$200K	Buy	+6,753	New	+$184K	﹤0.01%	1827
2014 Q3	–	Sell	-1,334,230	Closed	-$31.9M	–	930
2014 Q2	$31.9M	Buy	1,334,230 +455,850	+52%	+$11M	0.04%	459
2014 Q1	$23.4M	Buy	+878,380	New	+$20.9M	0.03%	534

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

OppenheimerFunds's GMED Position: Q1 2019 in Review

OppenheimerFunds opened a new position in Globus Medical (GMED) in Q1 2019: 5,353 shares worth $264K. The stake represents ﹤0.01% of the portfolio and ranks #1599 among its holdings. This is a return to the name: OppenheimerFunds previously reported a position in GMED as recently as Q3 2018.

OppenheimerFunds first reported a position in GMED in Q1 2014 and has held it in 10 quarters since. The position peaked at $31.9M in Q2 2014. 269 funds tracked by Wall St. Rank hold GMED as of Q1 2019.

OppenheimerFunds held 5,353 shares of Globus Medical worth $264K as of Q1 2019.
Globus Medical was a new OppenheimerFunds position in Q1 2019.
Globus Medical made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1599 holding.
OppenheimerFunds first reported a position in Globus Medical in Q1 2014 and has held it in 10 quarters since.
OppenheimerFunds's Globus Medical position peaked at $31.9M in Q2 2014.
269 funds tracked by Wall St. Rank held Globus Medical as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.